Skip to main content
logo
Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.294
-0.046 (-3.43%)
Feb 11, 2026, 1:57 PM EST - Market open

RANI Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
1.21.03--2.720.46
Revenue Growth (YoY)
----488.10%-52.81%
Gross Profit
1.21.03--2.720.46
Selling, General & Admin
20.1123.9526.4826.8427.834.96
Research & Development
22.1126.6839.6236.6126.4812.04
Operating Expenses
42.2250.6366.163.4554.3217.01
Operating Income
-41.02-49.6-66.1-63.45-51.6-16.54
Interest Expense
-3.67-5.03-5.09-1.07-0.47-0.12
Interest & Investment Income
0.81.763.31.250.090.06
Other Non Operating Income (Expenses)
-----0.37-0.06
EBT Excluding Unusual Items
-43.88-52.87-67.88-63.27-52.35-16.67
Asset Writedown
-3.71-3.71----
Other Unusual Items
-----0.7-
Pretax Income
-47.6-56.58-67.88-63.27-53.05-16.67
Income Tax Expense
---0.070.040.04
Earnings From Continuing Operations
-47.6-56.58-67.88-63.34-53.09-16.7
Minority Interest in Earnings
19.2826.5733.9132.7644.7616.7
Net Income
-28.32-30.02-33.97-30.59-8.33-
Net Income to Common
-28.32-30.02-33.97-30.59-8.33-
Shares Outstanding (Basic)
372826242047
Shares Outstanding (Diluted)
372826242047
Shares Change (YoY)
39.37%11.65%7.09%21.93%-58.34%-
EPS (Basic)
-0.76-1.05-1.33-1.28-0.43-
EPS (Diluted)
-0.76-1.05-1.33-1.28-0.43-
Free Cash Flow
-27.78-35.76-52.47-48.13-32.75-16.16
Free Cash Flow Per Share
-0.74-1.26-2.06-2.02-1.68-0.34
Gross Margin
100.00%100.00%--100.00%100.00%
Operating Margin
-3418.25%-4824.90%---1899.12%-3580.95%
Profit Margin
-2359.58%-2920.04%---306.63%-
Free Cash Flow Margin
-2315.17%-3478.99%---1205.41%-3497.84%
EBITDA
-40.04-48.57-65.28-62.9-51.1-15.96
D&A For EBITDA
0.981.030.820.550.50.59
EBIT
-41.02-49.6-66.1-63.45-51.6-16.54
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q